Docoh
Loading...

Alon Lazarus

Alon Lazarus is a director of Werewolf Therapeutics Inc.

Person profile

Roles
Address
Lexington, Massachusetts
Employees
SEC CIK

Calendar

17 May 21
Date Company Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
4 May 21 HOWL Werewolf Therapeutics Common Stock Buy Aquire P Yes No 16 400,000 6.4M 2,046,634
4 May 21 HOWL Werewolf Therapeutics Common Stock Conversion Aquire C Yes No 0 410,717 0 1,646,634
4 May 21 HOWL Werewolf Therapeutics Common Stock Conversion Aquire C Yes No 0 1,235,917 0 1,235,917
4 May 21 HOWL Werewolf Therapeutics Series B Preferred Stock Common Stock Conversion Dispose C Yes No 0 3,560,551 0 0
4 May 21 HOWL Werewolf Therapeutics Series A Preferred Stock Common Stock Conversion Dispose C Yes No 0 10,714,284 0 0
30 Apr 21 HOWL Werewolf Therapeutics Stock Option Common Stock Grant Aquire A No No 16 23,200 371.2K 23,200
23 Dec 20 HOWL Werewolf Therapeutics Series B Preferred Stock Common Stock Buy Aquire P Yes No 0.9214 3,560,551 3.28M 3,560,551
13 Apr 20 KROS Keros Therapeutics Common Stock Buy Aquire P Yes No 16 120,000 1.92M 2,013,102
13 Apr 20 KROS Keros Therapeutics Common Stock Conversion Aquire C Yes No 0 167,537 0 1,893,102
13 Apr 20 KROS Keros Therapeutics Common Stock Conversion Aquire C Yes No 0 343,270 0 1,725,565

Financial reports

No filings

Current reports

No filings

Registration and prospectus

No filings

Proxies

No filings

Other

No filings